Express Scripts Holding Co. (ESRX)

87.18
0.16 0.18
NASDAQ : Health Services
Prev Close 87.34
Open 87.48
Day Low/High 86.77 / 87.59
52 Wk Low/High 55.80 / 87.69
Volume 1.36M
Avg Volume 3.54M
Exchange NASDAQ
Shares Outstanding 562.23M
Market Cap 48.72B
EPS 7.80
P/E Ratio 10.66
Div & Yield N.A. (N.A)

Latest News

Tesla and Musk, Cigna and Icahn, Home Depot, McDonald's - 5 Things You Must Know

Tesla and Musk, Cigna and Icahn, Home Depot, McDonald's - 5 Things You Must Know

U.S. stock futures rise on Tuesday as investors cautiously return to risk markets; Home Depot reports earnings; Tesla's Elon Musk says he's working with Silver Lake Partners and Goldman Sachs as advisers on his plans to take the electric car company private.

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement With Cigna

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement With Cigna

Express Scripts Reminds Stockholders to Vote "FOR" the Merger

Long-term Cigna Shareholder Glenview Capital Submits Open Letter To Shareholders In Support Of Cigna / Express Scripts Transaction

Long-term Cigna Shareholder Glenview Capital Submits Open Letter To Shareholders In Support Of Cigna / Express Scripts Transaction

NEW YORK, Aug. 9, 2018 /PRNewswire/ -- Fellow Cigna Shareholders: Our firm, Glenview Capital Management ("Glenview"), is a 10-year investor in Cigna (NYSE:CI), and we support the Express Scripts (NASDAQ:ESRX) transaction for the following reasons: 1.

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Jim Cramer talks about which companies and CEOs are being given the benefit of the doubt -- and which actually deserve it.

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Sometimes you gotta have faith, but you also have to be a little more skeptical.

Stocks End Higher; Tesla Surges

Stocks End Higher; Tesla Surges

Stocks ended higher Tuesday after China moved to support shares in Shanghai and on positive earnings and takeover talk.

Cigna Shreds Billionaire Carl Icahn's Critique of Express Scripts Deal

Cigna Shreds Billionaire Carl Icahn's Critique of Express Scripts Deal

Cigna argues Carl Icahn is only looking out for himself in trying to block Express Scripts deal.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

All three major indices rose Tuesday afternoon.

Jim Cramer on Apple, Alphabet, Amazon, Disney, Cigna and Express Scripts

Jim Cramer on Apple, Alphabet, Amazon, Disney, Cigna and Express Scripts

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's stocks from the floor of the New York Stock Exchange.

Jim Cramer: I Want the Cigna-Express Scripts Deal to Close

Jim Cramer: I Want the Cigna-Express Scripts Deal to Close

Activist investor Carl Icahn slammed Cigna's move to acquire Express Scripts.

Tesla's Stock Is Losing Momentum Just as the Market Nears Its All-Time Record

Tesla's Stock Is Losing Momentum Just as the Market Nears Its All-Time Record

The summer battle on Wall Street is on: Cigna vs. billionaire activist investor Carl Icahn. Stocks, meanwhile, continue to ascend to new heights despite a host of concerns.

Walt Disney, Papa John's, AT&T, Cigna, Weight Watchers - 5 Things You Must Know

Walt Disney, Papa John's, AT&T, Cigna, Weight Watchers - 5 Things You Must Know

U.S. stock futures are higher on Tuesday as earnings continue to impress; Walt Disney, Snap and Papa John's report earnings on Tuesday; the Justice Department challenges a judge's approval of the AT&T-Time Warner merger.

Express Scripts Announces New Recommendations Tackling High Drug Prices

Express Scripts Announces New Recommendations Tackling High Drug Prices

- 2019 National Preferred Formulary includes low list price medications in high-cost categories

Carl Icahn Attacks 'Cigna's $60 Billion Folly', Urges Rejection of Scripts Deal

Carl Icahn Attacks 'Cigna's $60 Billion Folly', Urges Rejection of Scripts Deal

Billionaire Investor Carl Icahn urged Cigna shareholders Tuesday to reject the company's planned acquisition of Express Scripts Holdings Co., calling the deal a "$60 billion folly".

Stocks Recover From Trade Jitters to End Mostly Higher

Stocks Recover From Trade Jitters to End Mostly Higher

After starting with a sharp selloff on the latest trade tensions with China, U.S. stocks bounced back to end mostly higher Thursday.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Nasdaq closed at its session high.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Nasdaq was the lone major U.S. index to close trading in the green Wednesday.

Express Scripts Announces 2018 Second Quarter Results

Express Scripts Announces 2018 Second Quarter Results

- Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth

Apple, Tesla, Federal Reserve - 5 Things You Must Know Before the Market Opens

Apple, Tesla, Federal Reserve - 5 Things You Must Know Before the Market Opens

U.S. stock futures are mixed amid reports of an escalation of trade tensions between the U.S. and China; Apple posts stronger-than-expected quarterly profit; analysts are non-committal on Tesla.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cigna Corporation - CI

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cigna Corporation - CI

NEW YORK, July 26, 2018 /PRNewswire/ --  Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Cigna Corporation ("Cigna" or...

Morgan Stanley M&A Prowess to Remain Strong; Google Dealt Another EU Fine--ICYMI

Morgan Stanley M&A Prowess to Remain Strong; Google Dealt Another EU Fine--ICYMI

Here's what you need to know now for Wednesday, July 18.

Express Scripts Subsidiary Expands Services To Healthcare Providers, Adding 100 Jobs In St. Louis

Express Scripts Subsidiary Expands Services To Healthcare Providers, Adding 100 Jobs In St. Louis

eviCore Medical Benefit Management Opens New Provider Service Center

WeissLaw LLP Files Class Action Lawsuit Against Express Scripts Holding Company

WeissLaw LLP Files Class Action Lawsuit Against Express Scripts Holding Company

NEW YORK, July 12, 2018 /PRNewswire/ -- WeissLaw LLP announced that it has filed a class action on behalf of shareholders of Express Scripts Holding Company ("Express Scripts") (NASDAQ: ESRX) seeking to pursue remedies under the Securities Exchange Act of...

Express Scripts Named A Best Place To Work For Disability Inclusion

Express Scripts Named A Best Place To Work For Disability Inclusion

ST. LOUIS, July 11, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was again recognized with a 100 percent score on the Disability Equality Index® (DEI) for its ongoing commitment to being inclusive and welcoming to people of all abilities.

By the Numbers: Second Quarter Was All About Doing the Big Deal

By the Numbers: Second Quarter Was All About Doing the Big Deal

Companies didn't hesitate to pull the trigger on some big deals in the quarter.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Express Scripts Holding Co. - ESRX

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Express Scripts Holding Co. - ESRX

NEW YORK, June 28, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Express Scripts Holding Co.

AT&T-Time Warner Ruling Could Usher in More Healthcare Deals

AT&T-Time Warner Ruling Could Usher in More Healthcare Deals

On the heels of the landmark antitrust decision, Bain's Kara Murphy expects to see more healthcare transactions.

TheStreet Quant Rating: B (Buy)